Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Sarcoma × Triptorelin Pamoate × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Prostatic Neoplasms 2 Lymphoma 2 The Neoadjuvant Therapy 1 Sarcoma, Ewing 1 Sarcoma 1 Osteosarcoma 1 Neoplasms 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1

Interventions

Doxorubicin 3 Radiotherapy 2 Drug Therapy 2 pirarubicin 1 pazopanib 1 liposomal doxorubicin 1 anlotinib 1 Triptorelin Pamoate 1 Trabectedin 1 Radiation 1 Methotrexate 1 Ifosfamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02856048 2019-12-17

PRESOV

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Unknown

LymphoidSarcoma

Lymphoma, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡